Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Molecular and Cellular Biology|April 23, 2008
Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitinationM Guy Roukens, Mariam Alloul-Ramdhani, Setareh Moghadasi, et al.Human Mutation|January 19, 2016
Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition GenesSetareh Moghadasi, Diana M Eccles, Peter Devilee, et al.American Journal of Medical Genetics. Part A|August 16, 2014
A terminal 3p26.3 deletion is not associated with dysmorphic features and intellectual disability in a four-generation familySetareh Moghadasi, Arie van Haeringen, Lieke Langendonck, et al.Journal of Medical Genetics|December 13, 2012
Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counsellingSetareh Moghadasi, Nandy Hofland, Joyce N Wouts, et al.Breast Cancer Research and Treatment|August 15, 2018
Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)Emma Tudini, Setareh Moghadasi, Michael T Parsons, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation AssaysPeter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, et al.European Heart Journal. Case Reports|October 27, 2021
Case series, chemotherapy-induced cardiomyopathy: mind the family history!Setareh Moghadasi, Rienke Fijn, Saskia L M A Beeres, et al.Journal of Medical Genetics|December 18, 2025
Evidence for pathogenicity of BRCA2 c.8351G>A p.(Arg2784Gln) and the challenges in classification of pathogenic variants with reduced penetranceSetareh Moghadasi, Maria Zanti, Fonnet Bleeker, et al.Journal of Medical Genetics|May 12, 2017
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortiumSetareh Moghadasi, Huong D Meeks, Maaike Pg Vreeswijk, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Putting genome-wide sequencing in neonates into perspectivePleuntje J van der Sluijs, Emmelien Aten, Daniela Q C M Barge-Schaapveld, et al.Pageof 2